Pharmacare v. Caremark

965 F. Supp. 1411, 1996 U.S. Dist. LEXIS 20504, 1996 WL 806141
CourtDistrict Court, D. Hawaii
DecidedDecember 12, 1996
DocketCivil 96-00474 ACK
StatusPublished
Cited by8 cases

This text of 965 F. Supp. 1411 (Pharmacare v. Caremark) is published on Counsel Stack Legal Research, covering District Court, D. Hawaii primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pharmacare v. Caremark, 965 F. Supp. 1411, 1996 U.S. Dist. LEXIS 20504, 1996 WL 806141 (D. Haw. 1996).

Opinion

ORDER GRANTING IN PART AND DENTING IN PART DEFENDANTS’ MOTION TO DISMISS. THE COURT GRANTS DEFENDANTS’ MOTION TO DISMISS WITH LEAVE TO AMEND REGARDING: (1) PLAINTIFFS’ WIRE AND MAIL FRAUD CLAIMS; AND (2) PLAINTIFFS’ § 1962(a) CLAIM. THE COURT DENIES THE REMAINDER OF DEFENDANTS’ MOTION TO DISMISS

KAY, Chief Judge.

BACKGROUND

This case concerns the alternate site infusion therapy industry. Alternate site infusion therapies consist of services involving the administration of medication, nutritional solutions and fluids to a patient outside of a hospital. The most common therapies include total parental nutrition, enternal nutrition, antibiotic, antiviral and antifungal therapies, chemotherapy, pain management therapy, human growth therapy and treatments for hemophilia and HIV AIDS. Due to their medical nature, alternative site infusion therapies are typically prescribed by a patient’s doctor. From February 1986 until April 1995, when it sold its alternate site infusion therapy business, Caremark, Inc. (“Caremark”) was the largest company in this industry.

During this time, Caremark underwent certain corporate transformations. Prior to 1987, Caremark was known as Home Health Care of America. From approximately August 1987 to about November 1992, Care-mark was owned by Baxter Healthcare Corporation (“Baxter Healthcare”), a Delaware Corporation with its principal place of business in Illinois. Baxter Healthcare is a subsidiary of Baxter International, Inc (“Baxter”), a Delaware corporation with its headquarters in Illinois. In November, 1992, Caremark became a subsidiary of Caremark International, Inc. (collectively Caremark, Caremark International, Inc., Baxter Healthcare and Baxter referred to as “Defendants”).

This ease came about because of two plea agreements entered into by Caremark in the District of Minnesota (“Minnesota plea”) and *1414 the Southern District of Ohio (“Ohio plea”). In the Minnesota plea, entered into on June 20, 1995, Caremark pled guilty to one count of mail fraud in violation of 18 U.S.C. § 1341 and agreed to pay a fine of $9,000,000. Two days later on June 22, 1995, Caremark entered into the Ohio plea where it pled guilty to mail fraud and paid a $20,000,000 fine. The basis for these agreements was Care-mark’s improper payments to physicians in exchange for the physicians’ referrals of patients.

The significance and scope of these agreements constitute the gist of this action. The Defendants argue that the agreements merely establish wrongdoing with regard to two doctors 1 in the Minneapolis and Columbus area concerning the Federal Employees Health Benefit Program (“FEHBP”) and the Civilian Health and Medical Program of the Uniformed Services (“CHAMPUS”), two federal programs.

Caremark’s competitors disagree. They argue that these agreements evidence a nationwide scheme of commercial bribery. In fact, three competitors 2 (“Plaintiffs”) filed a nationwide class action on May 20, 1996 against the Defendants. The complaint asserts that Defendants’ scheme violated four different statutes: (1) Clayton Act § 2(e) as amended by the Robinson-Patman Act, 15 U.S.C. § 13(c) (“ § 2(c)”); (2) RICO 18 U.S.C. § 1962(a) and (d) (“ § 1962(a)”); (3) RICO 18 U.S.C. § 1962(e) and (d) (“ § 1962(e)”); and (4) the California Business & Professions Code § 17200 concerning unfair and fraudulent business practices (“pendent claim”). For these violations, Plaintiffs seek general damages (trebled as provided by law), attorney’s fees, an injunction prohibiting the Defendants from continuing their actions, restitution of Defendants’ ill-gotten gains, and the imposition of a constructive trust.

On August 26,1996, the Defendants filed a motion to dismiss. With regard to the RICO claims, Defendants argue that Plaintiffs’ complaint fails to: (1) adequately establish the predicate acts of racketeering; (2) satisfy RICO’s proximate cause and standing requirement; (3) establish the existence of an enterprise necessary for § 1962(c); and (4) establish that Plaintiffs were injured by Defendants’ use of income derived from racketeering activity as required by § 1962(a). As to Plaintiffs’ § 2(c) claim, Defendants argue that dismissal is appropriate because: (1) Plaintiffs lack the requisite standing; (2) Doctors do not owe their patients a commercial duty; and (3) Plaintiffs failed to plead that doctors provided no services in return for the alleged payments. Finally, with regard to the pendent claim, Defendants sought dismissal on the grounds that: (1) the injunction sought is unnecessary; (2) the Plaintiffs lack standing; and (3) the relief sought would violate the Commerce Clause of the Federal Constitution.

Plaintiffs responded to all these arguments in their October 31, 1996 opposition. The Defendants filed a reply on November 7, 1996.

STANDARD OF REVIEW

1. Motion to Dismiss

Under Fed.R.Civ.P. 12(b)(6), in determining whether a motion to dismiss for failure to state a claim upon which relief can be granted, this Court must accept as true the plaintiffs allegations contained in the complaint and view them in a light most favorable to the plaintiff. Scheuer v. Rhodes, 416 U.S. 232, 236, 94 S.Ct. 1683, 1686, 40 L.Ed.2d 90 (1974); Wileman Bros. & Elliott, Inc. v. Giannini, 909 F.2d 332, 334 (9th Cir.1990); Shah v. County of Los Angeles, 797 F.2d 743, 745 (9th Cir.1986). Thus, the complaint must stand unless it appears beyond doubt that the plaintiff has alleged no facts that would entitle him to relief. Conley v. Gibson, 355 U.S. 41, 45-46, 78 S.Ct. 99, 101-02, 2 L.Ed.2d 80 (1957); Balistreri v. Pacifica Police Dept., 901 F.2d 696, 699 (9th Cir.1990). A complaint may be dismissed as a matter of law for two reasons: (1) lack of a cognizable legal *1415 theory or (2) insufficient facts under a cognizable legal theory. Balistreri, 901 F.2d at 699; Robertson v. Dean Witter Reynolds, Inc., 749 F.2d 530, 533-34 (9th Cir.1984).

In essence, as the Ninth Circuit has stated, “[t]he issue is not whether a plaintiffs success on the merits is likely but rather whether the claimant is entitled to proceed beyond the threshold in attempting to establish his claims.” De La Cruz v. Tormey,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hope for Families & Community Service, Inc. v. Warren
721 F. Supp. 2d 1079 (M.D. Alabama, 2010)
United States v. Bochicchio
23 F. App'x 751 (Ninth Circuit, 2001)
Bridges v. MacLean
First Circuit, 2000
Bridges v. MacLean-Stevens Studios, Inc.
201 F.3d 6 (First Circuit, 2000)
Dumas v. Major League Baseball Properties, Inc.
52 F. Supp. 2d 1170 (S.D. California, 1999)
Bridges v. MacLean-Stevens Studios, Inc.
35 F. Supp. 2d 20 (D. Maine, 1998)
VNA Plus, Inc. v. Apria Healthcare Group, Inc.
29 F. Supp. 2d 1253 (D. Kansas, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
965 F. Supp. 1411, 1996 U.S. Dist. LEXIS 20504, 1996 WL 806141, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pharmacare-v-caremark-hid-1996.